APA (7th ed.) Citation

Razak, A. A., Naing, A., Diep, A., Hwang, C., Reisetter, A., Fuller, Z., . . . Schmidt, M. (2024). 150P Phase I/IIa trial of CD200R1 inhibitor 23ME-00610: Exploratory analyses of tissue-based and genetic biomarkers. Annals of Oncology, 35, S274. https://doi.org/10.1016/j.annonc.2024.08.158

Chicago Style (17th ed.) Citation

Razak, A.R. Abdul, A. Naing, A.N Diep, C.C Hwang, A.C Reisetter, Z.L Fuller, C. Hom, D.M Glatt, and M. Schmidt. "150P Phase I/IIa Trial of CD200R1 Inhibitor 23ME-00610: Exploratory Analyses of Tissue-based and Genetic Biomarkers." Annals of Oncology 35 (2024): S274. https://doi.org/10.1016/j.annonc.2024.08.158.

MLA (9th ed.) Citation

Razak, A.R. Abdul, et al. "150P Phase I/IIa Trial of CD200R1 Inhibitor 23ME-00610: Exploratory Analyses of Tissue-based and Genetic Biomarkers." Annals of Oncology, vol. 35, 2024, p. S274, https://doi.org/10.1016/j.annonc.2024.08.158.